STTK - Shattuck Labs, Inc.
IEX Last Trade
1.11
0 0%
Share volume: 6,494
Last Updated: Thu 26 Dec 2024 08:27:57 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$1.11
0.00
0.00%
Fundamental analysis
17%
Profitability
8%
Dept financing
3%
Liquidity
75%
Performance
16%
Performance
5 Days
0.91%
1 Month
2.78%
3 Months
-70.16%
6 Months
-70.71%
1 Year
-83.19%
2 Year
-53.94%
Key data
Stock price
$1.11
DAY RANGE
$1.08 - $1.14
52 WEEK RANGE
$1.02 - $11.76
52 WEEK CHANGE
-$84.67
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
Company detail
CEO: Taylor H. Schreiber
Region: US
Website: shattucklabs.com
Employees: 100
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: shattucklabs.com
Employees: 100
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company was incorporated in 2016 and is headquartered in Austin, Texas.
Recent news